FDA Releases Final Label Revision And TA ANDA Amendment Guidances
The FDA Aims To Improve The Development, Review, And Approval Process Of Generic Drugs
Executive Summary
While the new guidance on ANDA label revision “provides clear expectations” from the FDA, the revised guidance on amendments to tentatively approved ANDAs is yet to answer questions from AAM.